The authors declare that they have no competing interests.
LGOB conceived and designed the study, analyzed the data and revised the article; RMM conceived and designed the study, acquired and analyzed the data and draft/revised the article; CSV, RAF, RMR, AAN participated in analyzing data and revising the article. All authors approved the final version of the article.
Uterine leiomyoma is the most common gynecological tumor in the reproductive years. However, it is extremely rare in adolescence (<1%), with few reports found in the literature. The biological behavior of such tumors in this age group is unknown, as well as the best possible treatment for this population. We aimed to analyze all available reports of uterine leiomyoma in adolescence.
A systematic review was performed at PubMed/MEDLINE and EMBASE. Between 1965 and 2014, 19 reports were found on uterine leiomyoma in patients under 18 years. The following parameters were discussed: age, tumor diameter, symptoms, clinical treatments, surgical treatments, hemodynamic changes.
Mean age was 15.35 (14–17) years. Mean tumor diameter was 12.28 cm (3–30) and median diameter was 10 cm. Most patients presented with symptoms (87.5%), including abnormal uterine bleeding (10/18) and pelvic/abdominal pain (6/18). A pelvic mass was the most common finding. Two patients required transfusion due to anemia. One patient underwent abdominal hysterectomy, and the others underwent myomectomy. Mean follow-up was 1 year and 8 months, and only case recurred, after 6 months.
Leiomyomas’ biologic behavior in adolescents may be different from that of older women, but their molecular characteristics still haven’t been analyzed. Optimal treatment is still not defined, but myomectomy has several advantages in this population. Leiomyomas must be remembered as an important differential diagnosis of pelvic mass in adolescents.
Parker W. Etiology, symptomotology and diagnosis of uterine myomas. Fert Steril. 2007;87:725–36. CrossRef
Wisot AL, Neimand KM, Rosenthal AH. Symptomatic myoma in a 13-year-old girl. Am J Obstet Gynecol. 1969;105(4):639–41. PubMed
Horejsi J, Zuntova A, Urbanova H. Giant leiomyoma uteri in a 15-year-old girl. J Pediatr Adolesc Gynecol. 1988;1(4):267–70. CrossRef
Wright KN, Laufer MR. Leiomyomas in adolescents. Fertil Steril. 2011;95(7):e2415–37. 2434. CrossRef
Morad NA, El-Said MM. Cellular uterine myoma causing vaginal bleeding in a 15-year-old girl. Aust N Z Obstet Gynaecol. 1993;33(2):211–3. CrossRef
Bekker G, Gavrilescu T, Rickets-Holcomb L, Puka-Khandam P, Akhtar A, Ansari A. Symptomatic fibroid uterus in a 15-year-old girl. Int Surg. 2004;89(2):80–2. PubMed
Grapsa D, Smyomiotis V, Hasiakos D, Kontogianni-Katsarou K, Kondi-Pafiti A. A giant uterine leiomyoma simulating an ovarian mass in a 16-year-old girl: a case report and review of the literature. Eur J Gynaecol Oncol. 2006;27(3):294–6. PubMed
Perez Colon L, Colon V, Laboy Torres J, Arias W. Protuse vaginal bleeding in an adolescent with a cervical myoma: a case report. Bol Asoc Med P R. 2011;103(2):65–6. PubMed
Nguyen-Duc H. Large uterine fibroma in a 15 year old adolescent. J Gynecol Obstet Biol Reprod. 2003;32:748–50.
Karim T, Patil K, Panchal A, Basu C. Presentation and management of giant fibroid uterus in an adolescent girl. Open Access Surg. 2010;3:13–5. CrossRef
Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Long-term treatment of uterine fibroids with ulipristal acetate. Fert Steril. 2014;101(6):1565–73. CrossRef
Song H, Lu D, Navaratnam K, Shi G. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013;10:CD009505. PubMed
- Presentation and treatment of uterine leiomyoma in adolescence: a systematic review
Rafael Mendes Moroni
Carolina Sales Vieira
Rui Alberto Ferriani
Rosana Maria dos Reis
Antonio Alberto Nogueira
Luiz Gustavo Oliveira Brito
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
e.Med Kampagnen-Visual, Mail Icon II